Last 12 months
Inside the activity.
0 purchase rows · 39 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 6 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 21 |
| Apr 2026 | 0 | 7 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 13, 2023 Filed Jun 15, 2023 20:32 UTC |
Owen Adams CatherineDirector
|
GrantRestricted stock units · Derivative | 5,929 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-23-000089 · wk-form4_1686861126.xml · derivative · entry 1 Owen Catherine E. · CIK 0001816838 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,929 Underlying: Common stock · 5,929 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units were granted on June 13, 2023. Beginning on June 13, 2024, the shares underlying the stock units will vest in three equal annual installments. Vested shares will be delivered to the reporting person within three business days after such shares become vested. F2 · derivative.expiration_date: The restricted stock units were granted on June 13, 2023. Beginning on June 13, 2024, the shares underlying the stock units will vest in three equal annual installments. Vested shares will be delivered to the reporting person within three business days after such shares become vested. Read SEC document |
| June 13, 2023 Filed Jun 15, 2023 20:25 UTC |
Ballal Rahul D.Director
|
GrantStock options (right to buy) · Derivative | 18,958 | $0.00 Strike: $26.56 | $0.00 |
DisclosureSEC source: 0001439222-23-000079 · wk-form4_1686860710.xml · derivative · entry 2 Ballal Rahul D. · CIK 0001805097 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,958 Underlying: Common stock · 18,958 shares Expires 2033-06-13 F3 · derivative.exercise_date: This option was granted on June 13, 2023. The shares underlying this option vest as to 100% of the underlying shares on June 13, 2024. Read SEC document |
| June 13, 2023 Filed Jun 15, 2023 20:25 UTC |
Ballal Rahul D.Director
|
GrantRestricted stock units · Derivative | 3,388 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-23-000079 · wk-form4_1686860710.xml · derivative · entry 1 Ballal Rahul D. · CIK 0001805097 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,388 Underlying: Common stock · 3,388 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units were granted on June 13, 2023. The shares underlying the stock units will vest in full on June 13, 2024. Vested shares will be delivered to the reporting person within three business days after such shares become vested. F2 · derivative.expiration_date: The restricted stock units were granted on June 13, 2023. The shares underlying the stock units will vest in full on June 13, 2024. Vested shares will be delivered to the reporting person within three business days after such shares become vested. Read SEC document |
| June 13, 2023 Filed Jun 15, 2023 20:30 UTC |
CAPELLO JEFFREY DDirector
|
GrantStock options (right to buy) · Derivative | 33,177 | $0.00 Strike: $26.56 | $0.00 |
DisclosureSEC source: 0001439222-23-000087 · wk-form4_1686861037.xml · derivative · entry 2 CAPELLO JEFFREY D · CIK 0001224108 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,177 Underlying: Common stock · 33,177 shares Expires 2033-06-13 F3 · derivative.exercise_date: This option was granted on June 13, 2023. The shares underlying this option vest as to 25% of the underlying shares on June 13, 2024, with the remaining 75% vesting in 36 equal monthly installments thereafter. Read SEC document |
| June 13, 2023 Filed Jun 15, 2023 20:30 UTC |
CAPELLO JEFFREY DDirector
|
GrantRestricted stock units · Derivative | 5,929 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-23-000087 · wk-form4_1686861037.xml · derivative · entry 1 CAPELLO JEFFREY D · CIK 0001224108 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,929 Underlying: Common stock · 5,929 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units were granted on June 13, 2023. Beginning on June 13, 2024, the shares underlying the stock units will vest in three equal annual installments. Vested shares will be delivered to the reporting person within three business days after such shares become vested. F2 · derivative.expiration_date: The restricted stock units were granted on June 13, 2023. Beginning on June 13, 2024, the shares underlying the stock units will vest in three equal annual installments. Vested shares will be delivered to the reporting person within three business days after such shares become vested. Read SEC document |
| June 13, 2023 Filed Jun 15, 2023 20:29 UTC |
FOUSE JACQUALYN ADirector
|
GrantStock options (right to buy) · Derivative | 18,958 | $0.00 Strike: $26.56 | $0.00 |
DisclosureSEC source: 0001439222-23-000085 · wk-form4_1686860968.xml · derivative · entry 2 FOUSE JACQUALYN A · CIK 0001405288 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,958 Underlying: Common stock · 18,958 shares Expires 2033-06-13 F3 · derivative.exercise_date: This option was granted on June 13, 2023. The shares underlying this option vest as to 100% of the underlying shares on June 13, 2024. Read SEC document |
| June 13, 2023 Filed Jun 15, 2023 20:29 UTC |
FOUSE JACQUALYN ADirector
|
GrantRestricted stock units · Derivative | 3,388 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-23-000085 · wk-form4_1686860968.xml · derivative · entry 1 FOUSE JACQUALYN A · CIK 0001405288 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,388 Underlying: Common stock · 3,388 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units were granted on June 13, 2023. The shares underlying the stock units will vest in full on June 13, 2024. Vested shares will be delivered to the reporting person within three business days after such shares become vested. F2 · derivative.expiration_date: The restricted stock units were granted on June 13, 2023. The shares underlying the stock units will vest in full on June 13, 2024. Vested shares will be delivered to the reporting person within three business days after such shares become vested. Read SEC document |
| June 13, 2023 Filed Jun 15, 2023 20:28 UTC |
Scadden DavidDirector
|
GrantStock options (right to buy) · Derivative | 18,958 | $0.00 Strike: $26.56 | $0.00 |
DisclosureSEC source: 0001439222-23-000083 · wk-form4_1686860874.xml · derivative · entry 2 Scadden David · CIK 0001707715 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,958 Underlying: Common stock · 18,958 shares Expires 2033-06-13 F3 · derivative.exercise_date: This option was granted on June 13, 2023. The shares underlying this option vest as to 100% of the underlying shares on June 13, 2024. Read SEC document |
| June 13, 2023 Filed Jun 15, 2023 20:28 UTC |
Scadden DavidDirector
|
GrantRestricted stock units · Derivative | 3,388 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-23-000083 · wk-form4_1686860874.xml · derivative · entry 1 Scadden David · CIK 0001707715 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,388 Underlying: Common stock · 3,388 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units were granted on June 13, 2023. The shares underlying the stock units will vest in full on June 13, 2024. Vested shares will be delivered to the reporting person within three business days after such shares become vested. F2 · derivative.expiration_date: The restricted stock units were granted on June 13, 2023. The shares underlying the stock units will vest in full on June 13, 2024. Vested shares will be delivered to the reporting person within three business days after such shares become vested. Read SEC document |
| June 13, 2023 Filed Jun 15, 2023 20:26 UTC |
Schenkein David PDirector
|
GrantStock options (right to buy) · Derivative | 18,958 | $0.00 Strike: $26.56 | $0.00 |
DisclosureSEC source: 0001439222-23-000081 · wk-form4_1686860775.xml · derivative · entry 2 Schenkein David P · CIK 0001578200 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,958 Underlying: Common stock · 18,958 shares Expires 2033-06-13 F3 · derivative.exercise_date: This option was granted on June 13, 2023. The shares underlying this option vest as to 100% of the underlying shares on June 13, 2024. Read SEC document |
| June 13, 2023 Filed Jun 15, 2023 20:26 UTC |
Schenkein David PDirector
|
GrantRestricted stock units · Derivative | 3,388 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-23-000081 · wk-form4_1686860775.xml · derivative · entry 1 Schenkein David P · CIK 0001578200 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,388 Underlying: Common stock · 3,388 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units were granted on June 13, 2023. The shares underlying the stock units will vest in full on June 13, 2024. Vested shares will be delivered to the reporting person within three business days after such shares become vested. F2 · derivative.expiration_date: The restricted stock units were granted on June 13, 2023. The shares underlying the stock units will vest in full on June 13, 2024. Vested shares will be delivered to the reporting person within three business days after such shares become vested. Read SEC document |
| June 13, 2023 Filed Jun 15, 2023 20:23 UTC |
Ho MaykinDirector
|
GrantStock options (right to buy) · Derivative | 18,958 | $0.00 Strike: $26.56 | $0.00 |
DisclosureSEC source: 0001439222-23-000077 · wk-form4_1686860613.xml · derivative · entry 2 Ho Maykin · CIK 0001646395 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,958 Underlying: Common stock · 18,958 shares Expires 2033-06-13 F3 · derivative.exercise_date: This option was granted on June 13, 2023. The shares underlying this option vest as to 100% of the underlying shares on June 13, 2024. Read SEC document |
| June 13, 2023 Filed Jun 15, 2023 20:23 UTC |
Ho MaykinDirector
|
GrantRestricted stock units · Derivative | 3,388 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-23-000077 · wk-form4_1686860613.xml · derivative · entry 1 Ho Maykin · CIK 0001646395 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,388 Underlying: Common stock · 3,388 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units were granted on June 13, 2023. The shares underlying the stock units will vest in full on June 13, 2024. Vested shares will be delivered to the reporting person within three business days after such shares become vested. F2 · derivative.expiration_date: The restricted stock units were granted on June 13, 2023. The shares underlying the stock units will vest in full on June 13, 2024. Vested shares will be delivered to the reporting person within three business days after such shares become vested. Read SEC document |
| June 13, 2023 Filed Jun 15, 2023 20:22 UTC |
Smith CynthiaDirector
|
GrantStock options (right to buy) · Derivative | 18,958 | $0.00 Strike: $26.56 | $0.00 |
DisclosureSEC source: 0001439222-23-000075 · wk-form4_1686860511.xml · derivative · entry 2 Smith Cynthia · CIK 0001609480 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,958 Underlying: Common stock · 18,958 shares Expires 2033-06-13 F3 · derivative.exercise_date: This option was granted on June 13, 2023. The shares underlying this option vest as to 100% of the underlying shares on June 13, 2024. Read SEC document |
| June 13, 2023 Filed Jun 15, 2023 20:22 UTC |
Smith CynthiaDirector
|
GrantRestricted stock units · Derivative | 3,388 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-23-000075 · wk-form4_1686860511.xml · derivative · entry 1 Smith Cynthia · CIK 0001609480 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,388 Underlying: Common stock · 3,388 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units were granted on June 13, 2023. The shares underlying the stock units will vest in full on June 13, 2024. Vested shares will be delivered to the reporting person within three business days after such shares become vested. F2 · derivative.expiration_date: The restricted stock units were granted on June 13, 2023. The shares underlying the stock units will vest in full on June 13, 2024. Vested shares will be delivered to the reporting person within three business days after such shares become vested. Read SEC document |
| June 13, 2023 Filed Jun 15, 2023 20:20 UTC |
Foster-Cheek Kaye IDirector
|
GrantStock options (right to buy) · Derivative | 18,958 | $0.00 Strike: $26.56 | $0.00 |
DisclosureSEC source: 0001439222-23-000073 · wk-form4_1686860412.xml · derivative · entry 2 Foster-Cheek Kaye I · CIK 0001312622 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,958 Underlying: Common stock · 18,958 shares Expires 2033-06-13 F3 · derivative.exercise_date: This option was granted on June 13, 2023. The shares underlying this option vest as to 100% of the underlying shares on June 13, 2024. Read SEC document |
| June 13, 2023 Filed Jun 15, 2023 20:20 UTC |
Foster-Cheek Kaye IDirector
|
GrantRestricted stock units · Derivative | 3,388 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-23-000073 · wk-form4_1686860412.xml · derivative · entry 1 Foster-Cheek Kaye I · CIK 0001312622 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,388 Underlying: Common stock · 3,388 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units were granted on June 13, 2023. The shares underlying the stock units will vest in full on June 13, 2024. Vested shares will be delivered to the reporting person within three business days after such shares become vested. F2 · derivative.expiration_date: The restricted stock units were granted on June 13, 2023. The shares underlying the stock units will vest in full on June 13, 2024. Vested shares will be delivered to the reporting person within three business days after such shares become vested. Read SEC document |
| April 12, 2023 Filed Apr 12, 2023 20:17 UTC |
FOUSE JACQUALYN ADirector
|
Tax withholdingCommon stock | 4,731 | $21.35 | $101,006.85 |
DisclosureSEC source: 0001439222-23-000059 · wf-form4_168133063686204.xml · nonDerivative · entry 2 FOUSE JACQUALYN A · CIK 0001405288 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,784 Read SEC document |
| April 08, 2023 Filed Apr 12, 2023 20:17 UTC |
FOUSE JACQUALYN ADirector
|
Exercise / conversionRestricted stock units · Derivative | 15,933 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-23-000059 · wf-form4_168133063686204.xml · derivative · entry 3 FOUSE JACQUALYN A · CIK 0001405288 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,867 Underlying: Common stock · 15,933 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units were granted on April 8, 2022. Beginning on April 8, 2023, the shares underlying the restricted stock units will vest in three equal annual installments. F2 · derivative.expiration_date: The restricted stock units were granted on April 8, 2022. Beginning on April 8, 2023, the shares underlying the restricted stock units will vest in three equal annual installments. Read SEC document |
| April 08, 2023 Filed Apr 12, 2023 20:17 UTC |
FOUSE JACQUALYN ADirector
|
Exercise / conversionCommon stock | 15,933 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-23-000059 · wf-form4_168133063686204.xml · nonDerivative · entry 1 FOUSE JACQUALYN A · CIK 0001405288 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 98,515 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 03, 2023 Filed Apr 5, 2023 20:03 UTC |
Schenkein David PDirector
|
Exercise / conversionStock option (right to buy) · Derivative | 16,363 | $0.00 Strike: $9.05 | $0.00 |
DisclosureSEC source: 0001439222-23-000058 · wf-form4_168072499813992.xml · derivative · entry 5 Schenkein David P · CIK 0001578200 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 16,363 shares Expires 2023-04-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This option was originally granted on April 30, 2013 for the purchase of 136,363 shares of common stock. The option vests as to 50% of the underlying shares upon the achievement of a performance milestone, and as to the remaining 50% of upon the achievement of a second performance milestone. The Company's board of directors determined that the first performance milestone was achieved on December 3, 2015, resulting in the vesting of this option as to 68,181 shares. On January 26, 2017, the Company's board of directors determined that the second performance milestone was achieved, resulting in the vesting of this option as to the remaining 68,182 shares. Read SEC document |
| April 03, 2023 Filed Apr 5, 2023 20:03 UTC |
Schenkein David PDirector
|
SaleCommon stock | 16,363 | $22.85 | $373,894.55 |
DisclosureSEC source: 0001439222-23-000058 · wf-form4_168072499813992.xml · nonDerivative · entry 2 Schenkein David P · CIK 0001578200 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 117,879 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $22.49 to $23.42. The reporting person undertakes, upon request by the staff of the Securitiesand Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| April 03, 2023 Filed Apr 5, 2023 20:03 UTC |
Schenkein David PDirector
|
Exercise / conversionCommon stock | 16,363 | $9.05 | $148,085.15 |
DisclosureSEC source: 0001439222-23-000058 · wf-form4_168072499813992.xml · nonDerivative · entry 1 Schenkein David P · CIK 0001578200 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 134,242 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| March 27, 2023 Filed Mar 30, 2023 01:30 UTC |
Schenkein David PDirector
|
Exercise / conversionStock option (right to buy) · Derivative | 20,000 | $0.00 Strike: $9.05 | $0.00 |
DisclosureSEC source: 0001439222-23-000056 · wf-form4_168013982720168.xml · derivative · entry 5 Schenkein David P · CIK 0001578200 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,363 Underlying: Common stock · 20,000 shares Expires 2023-04-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This option was originally granted on April 30, 2013 for the purchase of 136,363 shares of common stock. The option vests as to 50% of the underlying shares upon the achievement of a performance milestone, and as to the remaining 50% of upon the achievement of a second performance milestone. The Company's board of directors determined that the first performance milestone was achieved on December 3, 2015, resulting in the vesting of this option as to 68,181 shares. On January 26, 2017, the Company's board of directors determined that the second performance milestone was achieved, resulting in the vesting of this option as to the remaining 68,182 shares. Read SEC document |
| March 27, 2023 Filed Mar 30, 2023 01:30 UTC |
Schenkein David PDirector
|
SaleCommon stock | 20,000 | $22.15 | $443,000.00 |
DisclosureSEC source: 0001439222-23-000056 · wf-form4_168013982720168.xml · nonDerivative · entry 2 Schenkein David P · CIK 0001578200 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 117,879 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $21.93 to $22.36. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| March 27, 2023 Filed Mar 30, 2023 01:30 UTC |
Schenkein David PDirector
|
Exercise / conversionCommon stock | 20,000 | $9.05 | $181,000.00 |
DisclosureSEC source: 0001439222-23-000056 · wf-form4_168013982720168.xml · nonDerivative · entry 1 Schenkein David P · CIK 0001578200 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 137,879 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| March 13, 2023 Filed Mar 15, 2023 21:11 UTC |
Schenkein David PDirector
|
Exercise / conversionStock option (right to buy) · Derivative | 20,000 | $0.00 Strike: $9.05 | $0.00 |
DisclosureSEC source: 0001439222-23-000055 · wf-form4_167891470531005.xml · derivative · entry 6 Schenkein David P · CIK 0001578200 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,363 Underlying: Common stock · 20,000 shares Expires 2023-04-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F7 · derivative.exercise_date: This option was originally granted on April 30, 2013 for the purchase of 136,363 shares of common stock. The option vests as to 50% of the underlying shares upon the achievement of a performance milestone, and as to the remaining 50% of upon the achievement of a second performance milestone. The Company's board of directors determined that the first performance milestone was achieved on December 3, 2015, resulting in the vesting of this option as to 68,181 shares. On January 26, 2017, the Company's board of directors determined that the second performance milestone was achieved, resulting in the vesting of this option as to the remaining 68,182 shares. Read SEC document |
| March 13, 2023 Filed Mar 15, 2023 21:11 UTC |
Schenkein David PDirector
|
SaleCommon stock | 1,667 | $22.72 | $37,874.24 |
DisclosureSEC source: 0001439222-23-000055 · wf-form4_167891470531005.xml · nonDerivative · entry 3 Schenkein David P · CIK 0001578200 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,879 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $22.67 to $22.81. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| March 13, 2023 Filed Mar 15, 2023 21:11 UTC |
Schenkein David PDirector
|
SaleCommon stock | 18,333 | $22.47 | $411,942.51 |
DisclosureSEC source: 0001439222-23-000055 · wf-form4_167891470531005.xml · nonDerivative · entry 2 Schenkein David P · CIK 0001578200 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,546 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $21.67 to $22.66. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| March 13, 2023 Filed Mar 15, 2023 21:11 UTC |
Schenkein David PDirector
|
Exercise / conversionCommon stock | 20,000 | $9.05 | $181,000.00 |
DisclosureSEC source: 0001439222-23-000055 · wf-form4_167891470531005.xml · nonDerivative · entry 1 Schenkein David P · CIK 0001578200 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,879 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| March 03, 2023 Filed Mar 3, 2023 21:05 UTC |
Gheuens SarahChief Medical Officer
|
Tax withholdingCommon stock | 1,134 | $25.02 | $28,372.68 |
DisclosureSEC source: 0001439222-23-000047 · wf-form4_167787751050589.xml · nonDerivative · entry 2 Gheuens Sarah · CIK 0001881190 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,116 Read SEC document |
| March 03, 2023 Filed Mar 3, 2023 21:06 UTC |
Burns James WilliamChief Legal Officer
|
Tax withholdingCommon stock | 1,129 | $25.02 | $28,247.58 |
DisclosureSEC source: 0001439222-23-000049 · wf-form4_167787758550061.xml · nonDerivative · entry 2 Burns James William · CIK 0001900772 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,242 Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 21:02 UTC |
Washburn Theodore James Jr.Principal Accounting Officer
|
SaleCommon stock | 504 | $24.29 | $12,242.16 |
DisclosureSEC source: 0001439222-23-000053 · wf-form4_167822295304274.xml · nonDerivative · entry 1 Washburn Theodore James Jr. · CIK 0001874199 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,741 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:05 UTC |
Gheuens SarahChief Medical Officer
|
Exercise / conversionRestricted stock units · Derivative | 3,833 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-23-000047 · wf-form4_167787751050589.xml · derivative · entry 5 Gheuens Sarah · CIK 0001881190 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,667 Underlying: Common stock · 3,833 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F5 · derivative.exercise_date: The restricted stock units were granted on March 1, 2022. Beginning on March 1, 2023, the shares underlying the restricted stock units will vest in three equal annual installments. F5 · derivative.expiration_date: The restricted stock units were granted on March 1, 2022. Beginning on March 1, 2023, the shares underlying the restricted stock units will vest in three equal annual installments. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:05 UTC |
Gheuens SarahChief Medical Officer
|
GrantStock options (right to buy) · Derivative | 44,000 | $0.00 Strike: $25.01 | $0.00 |
DisclosureSEC source: 0001439222-23-000047 · wf-form4_167787751050589.xml · derivative · entry 4 Gheuens Sarah · CIK 0001881190 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,000 Underlying: Common stock · 44,000 shares Expires 2033-03-01 F4 · derivative.exercise_date: This option was granted on March 1, 2023. The shares underlying this option vest as to 25% of the underlying shares on March 1, 2024, with the remaining 75% vesting in 36 equal monthly installments thereafter. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:05 UTC |
Gheuens SarahChief Medical Officer
|
GrantRestricted stock units · Derivative | 12,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-23-000047 · wf-form4_167787751050589.xml · derivative · entry 3 Gheuens Sarah · CIK 0001881190 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common stock · 12,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F3 · derivative.exercise_date: The restricted stock units were granted on March 1, 2023. Beginning on March 1, 2024, the shares underlying the restricted stock units will vest in three equal annual installments. F3 · derivative.expiration_date: The restricted stock units were granted on March 1, 2023. Beginning on March 1, 2024, the shares underlying the restricted stock units will vest in three equal annual installments. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:05 UTC |
Gheuens SarahChief Medical Officer
|
Exercise / conversionCommon stock | 3,833 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-23-000047 · wf-form4_167787751050589.xml · nonDerivative · entry 1 Gheuens Sarah · CIK 0001881190 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 408 shares purchased through the Company's employee stock purchase plan. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:08 UTC |
Washburn Theodore James Jr.Principal Accounting Officer
|
Exercise / conversionRestricted stock units · Derivative | 777 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-23-000051 · wf-form4_167787764712794.xml · derivative · entry 4 Washburn Theodore James Jr. · CIK 0001874199 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,554 Underlying: Common stock · 777 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F4 · derivative.exercise_date: The restricted stock units were granted on March 1, 2022. Beginning on March 1, 2023, the shares underlying the restricted stock units will vest in three equal annual installments. F4 · derivative.expiration_date: The restricted stock units were granted on March 1, 2022. Beginning on March 1, 2023, the shares underlying the restricted stock units will vest in three equal annual installments. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:08 UTC |
Washburn Theodore James Jr.Principal Accounting Officer
|
GrantRestricted stock units · Derivative | 7,050 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-23-000051 · wf-form4_167787764712794.xml · derivative · entry 3 Washburn Theodore James Jr. · CIK 0001874199 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,050 Underlying: Common stock · 7,050 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F3 · derivative.exercise_date: The restricted stock units were granted on March 1, 2023. Beginning on March 1, 2024, the shares underlying the restricted stock units will vest in three equal annual installments. F3 · derivative.expiration_date: The restricted stock units were granted on March 1, 2023. Beginning on March 1, 2024, the shares underlying the restricted stock units will vest in three equal annual installments. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:08 UTC |
Washburn Theodore James Jr.Principal Accounting Officer
|
Tax withholdingCommon stock | 273 | $25.31 | $6,909.63 |
DisclosureSEC source: 0001439222-23-000051 · wf-form4_167787764712794.xml · nonDerivative · entry 2 Washburn Theodore James Jr. · CIK 0001874199 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,245 Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:08 UTC |
Washburn Theodore James Jr.Principal Accounting Officer
|
Exercise / conversionCommon stock | 777 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-23-000051 · wf-form4_167787764712794.xml · nonDerivative · entry 1 Washburn Theodore James Jr. · CIK 0001874199 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,518 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 73 shares purchased through the Company's employee stock purchase plan. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:07 UTC |
Jones CeciliaChief Financial Officer
|
GrantStock options (right to buy) · Derivative | 22,000 | $0.00 Strike: $25.01 | $0.00 |
DisclosureSEC source: 0001439222-23-000050 · wf-form4_167787761251341.xml · derivative · entry 2 Jones Cecilia · CIK 0001840056 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,000 Underlying: Common stock · 22,000 shares Expires 2033-03-01 F3 · derivative.exercise_date: This option was granted on March 1, 2023. The shares underlying this option vest as to 25% of the underlying shares on March 1, 2024, with the remaining 75% vesting in 36 equal monthly installments thereafter. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:07 UTC |
Jones CeciliaChief Financial Officer
|
GrantRestricted stock units · Derivative | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-23-000050 · wf-form4_167787761251341.xml · derivative · entry 1 Jones Cecilia · CIK 0001840056 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common stock · 6,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units were granted on March 1, 2023. Beginning on March 1, 2024, the shares underlying the restricted stock units will vest in three equal annual installments. F2 · derivative.expiration_date: The restricted stock units were granted on March 1, 2023. Beginning on March 1, 2024, the shares underlying the restricted stock units will vest in three equal annual installments. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:06 UTC |
Goff BrianDirector · Chief Executive Officer
|
GrantStock options (right to buy) · Derivative | 94,500 | $0.00 Strike: $25.01 | $0.00 |
DisclosureSEC source: 0001439222-23-000048 · wf-form4_167787754123125.xml · derivative · entry 2 Goff Brian · CIK 0001546216 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,500 Underlying: Common stock · 94,500 shares Expires 2033-03-01 F3 · derivative.exercise_date: This option was granted on March 1, 2023. The shares underlying this option vest as to 25% of the underlying shares on March 1, 2024, with the remaining 75% vesting in 36 equal monthly installments thereafter. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:06 UTC |
Goff BrianDirector · Chief Executive Officer
|
GrantRestricted stock units · Derivative | 25,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-23-000048 · wf-form4_167787754123125.xml · derivative · entry 1 Goff Brian · CIK 0001546216 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,500 Underlying: Common stock · 25,500 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units were granted on March 1, 2023. Beginning on March 1, 2024, the shares underlying the restricted stock units will vest in three equal annual installments. F2 · derivative.expiration_date: The restricted stock units were granted on March 1, 2023. Beginning on March 1, 2024, the shares underlying the restricted stock units will vest in three equal annual installments. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:06 UTC |
Burns James WilliamChief Legal Officer
|
Exercise / conversionRestricted stock units · Derivative | 3,833 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-23-000049 · wf-form4_167787758550061.xml · derivative · entry 5 Burns James William · CIK 0001900772 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,667 Underlying: Common stock · 3,833 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F4 · derivative.exercise_date: The restricted stock units were granted on March 1, 2022. Beginning on March 1, 2023, the shares underlying the restricted stock units will vest in three equal annual installments. F4 · derivative.expiration_date: The restricted stock units were granted on March 1, 2022. Beginning on March 1, 2023, the shares underlying the restricted stock units will vest in three equal annual installments. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:06 UTC |
Burns James WilliamChief Legal Officer
|
GrantStock options (right to buy) · Derivative | 44,000 | $0.00 Strike: $25.01 | $0.00 |
DisclosureSEC source: 0001439222-23-000049 · wf-form4_167787758550061.xml · derivative · entry 4 Burns James William · CIK 0001900772 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,000 Underlying: Common stock · 44,000 shares Expires 2033-03-01 F3 · derivative.exercise_date: This option was granted on March 1, 2023. The shares underlying this option vest as to 25% of the underlying shares on March 1, 2024, with the remaining 75% vesting in 36 equal monthly installments thereafter. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:06 UTC |
Burns James WilliamChief Legal Officer
|
GrantRestricted stock units · Derivative | 12,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-23-000049 · wf-form4_167787758550061.xml · derivative · entry 3 Burns James William · CIK 0001900772 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common stock · 12,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units were granted on March 1, 2023. Beginning on March 1, 2024, the shares underlying the restricted stock units will vest in three equal annual installments. F2 · derivative.expiration_date: The restricted stock units were granted on March 1, 2023. Beginning on March 1, 2024, the shares underlying the restricted stock units will vest in three equal annual installments. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:06 UTC |
Burns James WilliamChief Legal Officer
|
Exercise / conversionCommon stock | 3,833 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-23-000049 · wf-form4_167787758550061.xml · nonDerivative · entry 1 Burns James William · CIK 0001900772 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,371 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 21:06 UTC |
Schenkein David PDirector
|
Exercise / conversionStock option (right to buy) · Derivative | 20,000 | $0.00 Strike: $9.05 | $0.00 |
DisclosureSEC source: 0001439222-23-000041 · wf-form4_167770476285855.xml · derivative · entry 5 Schenkein David P · CIK 0001578200 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,363 Underlying: Common stock · 20,000 shares Expires 2023-04-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F6 · derivative.exercise_date: This option was originally granted on April 30, 2013 for the purchase of 136,363 shares of common stock. The option vests as to 50% of the underlying shares upon the achievement of a performance milestone, and as to the remaining 50% of upon the achievement of a second performance milestone. The Company's board of directors determined that the first performance milestone was achieved on December 3, 2015, resulting in the vesting of this option as to 68,181 shares. On January 26, 2017, the Company's board of directors determined that the second performance milestone was achieved, resulting in the vesting of this option as to the remaining 68,182 shares. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.